MedPath

Establishing First Trimester Markers for the Identification of High Risk Twin

Conditions
Small for Gestational Age (Disorder)
Pre-Eclampsia
Registration Number
NCT02031393
Lead Sponsor
Assaf-Harofeh Medical Center
Brief Summary

The purpose of this study is to determine whether we can establish different markers suc as mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood and more un the first trimester, in order to screen for twin pregnancies that are more likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • pregnant women from 11 -14 weeks of gestation
Exclusion Criteria
  • nuchal thickness above 3 mm,
  • Chronic hypertension,
  • thrombophilia,
  • Diabetes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The development of preeclampsiaafter delivery

the women will be approached after birth to asses whether they developed preeclampsia or pregnancy induced hypertension

Secondary Outcome Measures
NameTimeMethod
intra uterine growth restrictionafter delivery

Trial Locations

Locations (1)

Assaf Harofe obstetric department

🇮🇱

Be'er Ya'aqov, Zrifin, Israel

© Copyright 2025. All Rights Reserved by MedPath